GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OBI Pharma Inc (ROCO:4174) » Definitions » Days Sales Outstanding

OBI Pharma (ROCO:4174) Days Sales Outstanding : 61.88 (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is OBI Pharma Days Sales Outstanding?

OBI Pharma's average Accounts Receivable for the three months ended in Mar. 2024 was NT$6.20 Mil. OBI Pharma's Revenue for the three months ended in Mar. 2024 was NT$9.14 Mil. Hence, OBI Pharma's Days Sales Outstanding for the three months ended in Mar. 2024 was 61.88.

The historical rank and industry rank for OBI Pharma's Days Sales Outstanding or its related term are showing as below:

ROCO:4174' s Days Sales Outstanding Range Over the Past 10 Years
Min: 3.85   Med: 47.79   Max: 213.14
Current: 43.39

During the past 13 years, OBI Pharma's highest Days Sales Outstanding was 213.14. The lowest was 3.85. And the median was 47.79.

ROCO:4174's Days Sales Outstanding is ranked better than
74.83% of 882 companies
in the Biotechnology industry
Industry Median: 72.665 vs ROCO:4174: 43.39

OBI Pharma's Days Sales Outstanding declined from Mar. 2023 (135.93) to Mar. 2024 (61.88).


OBI Pharma Days Sales Outstanding Historical Data

The historical data trend for OBI Pharma's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OBI Pharma Days Sales Outstanding Chart

OBI Pharma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 78.21 3.85 47.79 213.14 37.40

OBI Pharma Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 135.93 54.19 53.23 28.32 61.88

Competitive Comparison of OBI Pharma's Days Sales Outstanding

For the Biotechnology subindustry, OBI Pharma's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OBI Pharma's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OBI Pharma's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where OBI Pharma's Days Sales Outstanding falls into.



OBI Pharma Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

OBI Pharma's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (2.037 + 6.477) / 2 ) / 41.549*365
=4.257 / 41.549*365
=37.40

OBI Pharma's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding (Q: Mar. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Mar. 2024 )) / count ) / Revenue (A: Mar. 2024 )*Days in Period
=( (6.477 + 5.913) / 2 ) / 9.135*365 / 4
=6.195 / 9.135*365 / 4
=61.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


OBI Pharma  (ROCO:4174) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


OBI Pharma Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of OBI Pharma's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


OBI Pharma (ROCO:4174) Business Description

Traded in Other Exchanges
N/A
Address
No. 3, Park Street, Room. 1907, 19th Floor, Nangang District, Taipei, TWN, 115
OBI Pharma Inc is part of the healthcare sector. The company and its subsidiaries are engaged in new drug research. Its focus is on the unmet medical need in challenging diseases throughout the world, such as cancer. OBI strives to improve health and the quality of life through cost-effective therapeutics. The Group has four reportable segments, which are the anti-cancer new drug segment, bispecific monoclonal antibody new drug segment, botulinum toxin new drug segment, and CDMO segment.

OBI Pharma (ROCO:4174) Headlines

No Headlines